Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs

We examined whether multidrug resistant (MDR) canine lymphoma increases gene expression for platelet-derived growth factor receptor α (PDGFRα), vascular endothelial growth factor receptor 2 (VEGFR2), and c-KIT, and whether toceranib phosphate (TOC) has potential as a treatment for MDR canine lymphom...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Vet Med Sci
Autors principals: YAMAZAKI, Hiroki, MIURA, Naoki, LAI, Yu-Chang, TAKAHASHI, Masashi, GOTO-KOSHINO, Yuko, YASUYUKI, Momoi, NAKAICHI, Munekazu, TSUJIMOTO, Hajime, SETOGUCHI, Asuka, ENDO, Yasuyuki
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Veterinary Science 2017
Matèries:
Internal Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5559368/
https://ncbi.nlm.nih.gov/pubmed/28592719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1292/jvms.16-0457
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars